eventscribe

The eventScribe Educational Program Planner system gives you access to information on sessions, special events, and the conference venue. Take a look at hotel maps to familiarize yourself with the venue, read biographies of our plenary speakers, and download handouts and resources for your sessions.

close this panel

SUBMIT FEEDBACKfeedback icon

Comments


close this panel
support

Technical Support


Phone: (410) 638-9239

Fax: (410) 638-6108

GoToMeeting: Meet Now!

Web: www.CadmiumCD.com

Submit Support Ticket

t on the system-->

close this panel
‹‹ Go Back

Cassandra Ballou

Oregon Health & Science University



‹‹ Go Back

Yiyi Chen

Oregon Health & Science University



�� Go Back

Please enter your access key

The asset you are trying to access is locked for premium users. Please enter your access key to unlock.


Email This Presentation:

From:

To:

Subject:

Body:

←Back IconGems-Print

701 – Dose Finding, Dose Response in Clinical Trials

A Response-Adaptive Covariate-Balanced Randomization for Multi-Arm Clinical Trials

Sponsor: Biopharmaceutical Section
Keywords: Clinical Trials, Multi-arm, Randomization, Response-adaptive, Covariate-balanced

Cassandra Ballou

Oregon Health & Science University

Yiyi Chen

Oregon Health & Science University

Randomization is a key characteristic of clinical trials which makes them the gold standard for determining treatment effectiveness. Response-adaptive randomization is often desired because it allows more patients to receive the winning treatment. Compared to traditional randomization response-adaptive randomization is more likely to allow imbalance in baseline covariates. We propose a simple yet flexible response-adaptive covariate-balanced randomization for multi-arm trials. For the response-adaptive component, we compared two approaches, the generalized drop-the-loser urn model and Ridit scoring. Likewise, for the covariate-balancing component, two approaches were considered, simple stratification and prognostic scoring. The operating characteristics of the proposed design were assessed via simulation for a variety of scenarios in which number of treatment arms, values of treatment success probability, and patient response delay time were varied. The performance of the newly proposed method was compared to non-response-adaptive and to Bayesian response-adaptive randomization methods to delineate for clinicians the circumstances where the purposed method should be adopted.

"eventScribe", the eventScribe logo, "CadmiumCD", and the CadmiumCD logo are trademarks of CadmiumCD LLC, and may not be copied, imitated or used, in whole or in part, without prior written permission from CadmiumCD. The appearance of these proceedings, customized graphics that are unique to these proceedings, and customized scripts are the service mark, trademark and/or trade dress of CadmiumCD and may not be copied, imitated or used, in whole or in part, without prior written notification. All other trademarks, slogans, company names or logos are the property of their respective owners. Reference to any products, services, processes or other information, by trade name, trademark, manufacturer, owner, or otherwise does not constitute or imply endorsement, sponsorship, or recommendation thereof by CadmiumCD.

As a user you may provide CadmiumCD with feedback. Any ideas or suggestions you provide through any feedback mechanisms on these proceedings may be used by CadmiumCD, at our sole discretion, including future modifications to the eventScribe product. You hereby grant to CadmiumCD and our assigns a perpetual, worldwide, fully transferable, sublicensable, irrevocable, royalty free license to use, reproduce, modify, create derivative works from, distribute, and display the feedback in any manner and for any purpose.

© 2015 CadmiumCD